Wedge Capital Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Wedge Capital Management’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-72,400	Closed	-$508K	–	594
2016 Q2	$508K	Buy	72,400 +16,100	+29%	+$113K	0.01%	430
2016 Q1	$372K	Buy	56,300 +9,500	+20%	+$69.9K	﹤0.01%	481
2015 Q4	$482K	Sell	46,800 -1,700	-4%	-$19.7K	0.01%	456
2015 Q3	$571K	Buy	48,500 +14,300	+42%	+$158K	0.01%	432
2015 Q2	$313K	Buy	+34,200	New	+$258K	﹤0.01%	536
2014 Q3	–	Sell	-141,200	Closed	-$967K	–	607
2014 Q2	$967K	Buy	141,200 +500	+0.4%	+$3.35K	0.01%	339
2014 Q1	$1.01M	Buy	140,700 +5,900	+4%	+$40.8K	0.01%	330
2013 Q4	$891K	Buy	+134,800	New	+$918K	0.01%	334

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Wedge Capital Management's JNP Position: Q3 2016 in Review

Wedge Capital Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2016, closing a stake of 72,400 shares — an estimated $508K sold.

Wedge Capital Management first reported a position in JNP in Q4 2013 and held it in 8 quarters. The position peaked at $1.01M in Q1 2014. 46 funds tracked by Wall St. Rank hold JNP as of Q3 2016.

Wedge Capital Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Wedge Capital Management sold 72,400 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2016, an estimated $508K.
Wedge Capital Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2013 and held it in 8 quarters.
Wedge Capital Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $1.01M in Q1 2014.
46 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2016.

Based on Wedge Capital Management's 13F filing for Q3 2016, filed 1 Nov 2016.